New patent expiration for Glaxosmithkline Llc drug LAMICTAL XR

Annual Drug Patent Expirations for LAMICTAL+XR Lamictal Xr is a drug marketed by Glaxosmithkline Llc and is included in one NDA. It is available from one supplier. There are two…

The post New patent expiration for Glaxosmithkline Llc drug LAMICTAL XR appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog